Patent 10086068 was granted and assigned to Aimmune Therapeutics on October, 2018 by the United States Patent and Trademark Office.
The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.